Profile: Radient Pharmaceuticals Corporation is engaged in the research, development, manufacturing, sales and marketing of in vitro diagnostic (IVD) & high end skin care products. Our Onko-Sure™ in vitro diagnostic test enables physicians and their patients to effectively monitor &/or detect solid tumor cancers by measuring the accumulation of specific breakdown products in the blood called fibrin & fibrinogen degradation products (FDP). It is a simple, non-invasive blood test used for the detection and/or monitoring of 14 different types of cancer including lung, breast, stomach, liver, colon, rectal, ovarian, esophageal, cervical, trophoblastic, thyroid, malignant lymphoma, & pancreatic. Elleuxe is our therapeutic, high-end skin care product line based on our proprietary active ingredient Elleuxe protein that offers cell renewing properties designed to minimize the appearance of aging.

The company was founded in 1987, has revenues of < USD 1 Million, has ~320 employees and is ISO 9001 certified. AMEX:ADL (SEC Filings)